Tetraspanin-enriched membrane microdomains in extracellular vesicles and cell adhesion and migration

Research summary:

Our group is focused on the characterization of tetraspanin-enriched microdomains (TEMs), specialized membrane platforms involved in cell-cell adhesion and migration processes. These membrane platforms are connected to different cytoskeletal components and signalling pathways. We have demonstrated a functional connection of tetraspanin CD81 with the dNTP hydrolase SAMHD1, that results in regulation of nucleotide metabolism downstream TEMs. This axis was proven to be relevant during HIV infectious cycle, and was protected through a patent that describes CD81 as a new target to fight against HIV infection.

In addition, tetraspanin proteins are among the most abundant proteins on extracellular vesicles (EVs). EVs represent a novel mechanism of intercellular communication as vehicles for bioactive proteins, lipids, and RNAs. In our group, we are exploiting the tools against tetraspanin molecules to develop new isolation, detection and quantification devices. We are also interested in deciphering the role of tetraspanins in EV biogenesis and uptake by the target cell. Finally, we are developing synthetic exosome mimetics by the use of tetraspanin-based tools.

Image

Figure 1. Tetraspanin-enriched microdomains and their functions. It has been demonstrated that TEM-induced clustering or segregation of adhesion receptors and signalling molecules plays a functional role in phenomena related to migration and invasion, intercellular adhesion, membrane fusion events and intracellular trafficking. These phenomena are implicated in several biological processes. From Yáñez-Mó et al., Trends Cell Biol. 2009 Sep;19(9):434-46.

Image

Figure 2. Tetraspanins in extracelular vesicle formation and function. Tetraspanins have the capacity to interact with several receptor and signaling molecules at the membrane, organizing specialized tetraspanin-enriched microdomains (TEMs) that may play a role in (A) EV biogenesis, (B) the selection of exosome cargo (proteins and miRNAs), (C) the binding and uptake of exosomes by target cells, or (D) the ability of exosomes to present antigen in the context of an immune response. From Andreu Z and Yáñez-Mó M. Front Immunol. 2014 Sep 16;5:442. doi: 10.3389/fimmu.2014.00442.

Image


* For external calls please dial 34 91196 followed by the extension number
Last nameNameLaboratoryExt.*e-mailProfessional category
Benayas LópezBeatriz4124425b.benayas(at)cbm.csic.esTitulado Sup.de Actividades Técn. y Profes. GP1
Lacruz PleguezuelosBlanca4094425Estudiante TFG
López MartínSoraya4124425Tco. de Investigación y Laboratorio
Toribio SerranoVíctor4124425Titulado Sup.de Actividades Técn. y Profes. GP1
Yáñez MoMaría4124639maria.yanez(at)cbm.csic.esProfesor Contratado Universidad, GA

Relevant publications:

  • Development of a quantitative method to measure EV uptake. Toribio V, Morales S, López-Martín S, Cardeñes B, Cabañas C, Yáñez-Mó M. Sci Rep. 2019 Jul 19;9(1):10522. doi: 10.1038/s41598-019-47023-9.
  • Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material. Lozano-Andrés E, Libregts SF, Toribio V, Royo F, Morales S, López-Martín S, Valés-Gómez M, Reyburn HT, Falcón-Pérez JM, Wauben MH, Soto M, Yáñez-Mó M. J Extracell Vesicles. 2019 Mar 4;8(1):1573052. doi: 10.1080/20013078.2019.1573052. eCollection 2019.
  • Tetraspanins, Another Piece in the HIV-1 Replication Puzzle. Suárez H, Rocha-Perugini V, Álvarez S, Yáñez-Mó M. Front Immunol. 2018 Aug 3;9:1811. doi: 10.3389/fimmu.2018.01811. eCollection 2018. Review. 
  • A bead-assisted flow cytometry method for the semi-quantitative analysis of Extracellular Vesicles. Suárez H, Gámez-Valero A, Reyes R, López-Martín S, Rodríguez MJ, Carrascosa JL, Cabañas C, Borràs FE, Yáñez-Mó M. Sci Rep. 2017 Sep 12;7(1):11271. doi: 10.1038/s41598-017-11249-2.
  • CD81 association with SAMHD1 enhances HIV-1 reverse transcription by increasing dNTP levels. Rocha-Perugini V, Suárez H, Álvarez S, López-Martín S, Lenzi GM, Vences-Catalán F, Levy S, Kim B, Muñoz-Fernández MA, Sánchez-Madrid F, Yáñez-Mó M. Nat Microbiol. 2017 Nov;2(11):1513-1522. doi: 10.1038/s41564-017-0019-0. Epub 2017 Sep 4.
  • Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression. Andreu Z, Otta Oshiro R, Redruello A, López-Martín S, Gutiérrez-Vázquez C, Morato E, Marina AI, Olivier Gómez C, Yáñez-Mó M. Eur J Pharm Sci. 2017 Feb 15;98:70-79. doi: 10.1016/j.ejps.2016.10.008. Epub 2016 Oct 15.
  • Comparative analysis of EV isolation procedures for miRNAs detection in serum samples. Andreu Z, Rivas E, Sanguino-Pascual A, Lamana A, Marazuela M, González-Alvaro I, Sánchez-Madrid F, de la Fuente H, Yáñez-Mó M. J Extracell Vesicles. 2016 Jun 20;5:31655. doi: 10.3402/jev.v5.31655. eCollection 2016.
  • Biological properties of extracellular vesicles and their physiological functions. Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Linē A, Lipps G, Llorente A, Lötvall J, Manček-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen EN, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O. J Extracell Vesicles. 2015 May 14;4:27066. doi: 10.3402/jev.v4.27066. eCollection 2015. PMID: 25979354
  • Tetraspanins in extracellular vesicle formation and function. Andreu Z, Yáñez-Mó M. Front Immunol. 2014 Sep 16;5:442. doi: 10.3389/fimmu.2014.00442. eCollection 2014. Review. PMID: 25278937

Doctoral theses:

  • 11/10/2019 “Papel de las tetraspaninas en la internalización y el tráfico de moléculas asociadas en modelos tumorales y de infección viral” Henar Suárez Montero. UAM. Sobresaliente “cum laude”
  • 15/02/2012 “CD81 regula la migración celular a través de su asociación con la GTPasa Rac” Emilio Tejera Puente. UAM. Sobresaliente “cum laude”
  • 20/06/2012 “Desarrollo de una nueva metodología para el análisis sistemático y a gran escala de interacciones proteína-proteína mediante espectrometría de masas: aplicación al estudio del interactoma intracelular de los microdominios enriquecidos en tetraspaninas de linfocitos T humanos” Daniel Pérez Hernandez. UAM. Sobresaliente “cum laude”
  • 16/07/2010 “Conexiones de los microdomiios ricos en tetraspaninas con el citoesqueleto de actina y su funcion en los procesos de migración y sinapsis inmune “ Mónica Sala-Valdés. UAM. Sobresaliente “cum laude”
  • 23/11/2009 “Función de las tetraspaninas y proteínas del citoesqueleto cortical de actina en la entrada del virus de la inmunodeficiencia humana (VIH-1) “ Mónica Gordón Alonso. UAM. Sobresaliente “cum laude”

Master theses:

  • 09/2012 “Study of the dynamic of endothelial adhesion receptors shedding during leukocyte extravasation” Sara Jiménez Torres. UAM. Sobresaliente.

  • 06/2016 “CD9 deletion using the CRISP/CAS9 system in melanoma cells”  Victor Toribio Serrano. UAM. Sobresaliente.


End of Degree supervised project:

  • 06/2015 “Desarrollo de herramientas moleculares basadas en las tetraspaninas para el estudio de vesículas extracelulares” Sara Morales. Biotecnología, UPM. Sobresaliente.

  • 06/2018 “Uso de herramientas basadas en tetraspaninas para la cuantificación y visualización de la captación de exosomas por parte de la célula diana.” Alba Orantes Fernández. Biología, UAM. Sobresaliente.

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

  • Accept cookies: if the user presses the acceptance button, this warning will not be displayed again when accessing any page of the portal.
  • Review the cookies policy: the user can access to this page in which the use of cookies is detailed, as well as links to modify the browser settings.

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: